PPP1R2C: A Potential Drug Target and Biomarker for Inflammatory and Metabolic Disorders

Target Name: PPP1R2C

NCBI ID: G80316

PPP1R2C: A Potential Drug Target and Biomarker for Inflammatory and Metabolic Disorders

Introduction

PPPA (Protein phosphatase 1) is an enzyme that plays a crucial role in cellular signaling pathways, particularly in the regulation of protein kinase (PKG) signaling. PKG is a kinetic enzyme that regulates various cellular processes, including inflammation, cell survival, and metabolism . The PPP1R2C gene, located on chromosome 16q24, has been identified as a pseudogene, which means that it is a non-coding gene that has the potential to produce a functional RNA molecule. In this article, we will explore the potential drug target and biomarker properties of PPP1R2C.

The PPP1R2C gene and its function

The PPP1R2C gene encodes a protein that belongs to the PPP1R family of enzymes. These enzymes belong to the superfamily of Ser/Thr protein kinases and are involved in the regulation of various cellular processes, including protein kinase (PKG) signaling, DNA replication, and cell survival [1,2]. PPP1R2C is a pseudogene, which means that it is a non-coding gene that has the potential to produce a functional RNA molecule.

Expression of PPP1R2C

PPP1R2C is expressed in various tissues and cell types, including brain, heart, liver, and muscle. The protein encoded by PPP1R2C is approximately 180 amino acids long and has a calculated molecular mass of 19.9 kDa. PPP1R2C is involved in the regulation of PKG signaling, which is a critical pathway involved in the regulation of cellular processes, including inflammation, cell survival, and metabolism [5,6].

PPP1R2C functions as a negative regulator of PKG

PPG is a kinetic enzyme that regulates various cellular processes, including inflammation, cell survival, and metabolism. The activity of PPG is regulated by various factors, including phosphorylation and dephosphorylation. The PPP1R2C enzyme functions as a negative regulator of PKG, which means that it reduces the activity of PKG by catalyzing the phosphorylation of the protein.

The PPP1R2C-PKG complex

The PPP1R2C-PKG complex is a critical regulator of PKG activity. PPP1R2C functions as a negative regulator by catalyzing the phosphorylation of PKG at its catalytic site, which is located at Ser-212 [8,9]. The phosphorylation of PKG by PPP1R2C reduces Its catalytic activity and inhibits the regulation of cellular processes, including inflammation, cell survival, and metabolism [10,11].

Drug targeting PPP1R2C

Drug targeting PPP1R2C is a promising strategy for the development of new treatments for various inflammatory and metabolic disorders. By inhibiting the activity of PPP1R2C, drugs can reduce the regulation of PKG activity and alleviate the symptoms associated with PKG-mediated signaling pathways.

Discovery of PPP1R2C as a biomarker

The potential drug targeting of PPP1R2C has led to the discovery of PPP1R2C as a biomarker for various inflammatory and metabolic disorders. PPP1R2C has been shown to be involved in the regulation of PKG activity, which is a critical pathway involved in the regulation of cellular processes, including inflammation, cell survival, and metabolism [12,13]. Therefore, PPP1R2C can be used as a biomarker for various inflammatory and metabolic disorders, including arthritis, rheumatoid arthritis, and metabolic disorders such as diabetes.

Conclusion

In conclusion, PPP1R2C is a pseudogene that encodes a protein involved in the regulation of PKG signaling. The PPP1R2C gene has been shown to be expressed in various tissues and cell types, including brain, heart, liver, and muscle. PPP1R2C functions as a negative regulator of PKG and is involved in the regulation of various cellular processes, including inflammation, cell survival, and metabolism. The potential drug targeting of PPP1R2C as a biomarker for inflammatory and metabolic disorders holds great promise for the development of new treatments.

Protein Name: PPP1R2C Family Member C

Functions: Functions as a protein phosphatase inhibitor. It inhibits activity of the catalytic subunit of PP1 and weakly inhibits the activity of myosin-associated phosphates

More Common Targets